Harmony Biosciences announces preliminary Q4 net product revenues of $201M
[ad_1]
Harmony Biosciences announces preliminary Q4 net product revenues of $201M
[ad_2]
Similar Posts
Brand prescription drugs to rise an average 4.5% in 2025
Byadmin
[ad_1] Brand prescription drugs to rise an average 4.5% in 2025 [ad_2]
Procore upgraded as it ranks among Jefferies 'top picks' for software in 2025
Byadmin
[ad_1] Procore upgraded as it ranks among Jefferies 'top picks' for software in 2025 [ad_2]
JPMorgan Chase GAAP EPS of $4.81 beats by $0.71, revenue of $43.74B beats by $2.18B
Byadmin
[ad_1] JPMorgan Chase GAAP EPS of $4.81 beats by $0.71, revenue of $43.74B beats by $2.18B [ad_2]
Nasdaq -1%, S&P slips as hot economic data eats into Fed rate cut bets
Byadmin
[ad_1] Nasdaq -1%, S&P slips as hot economic data eats into Fed rate cut bets [ad_2]
Disinflation path will be bumpy and take time, NY Fed's Williams says
Byadmin
[ad_1] Disinflation path will be bumpy and take time, NY Fed's Williams says [ad_2]
JPMorgan Diversified Return U.S. Small Cap Equity ETF declares quarterly distribution of $0.2920
Byadmin
[ad_1] JPMorgan Diversified Return U.S. Small Cap Equity ETF declares quarterly distribution of $0.2920 [ad_2]